A systematic review investigating the safety and efficacy of intravenous iron in people with ND-CKD who are iron deficient but not anaemic
Sebastian Spencer, Megan Skidmore, Rosa Maeve McGing, Sunil Bhandari · 2026
Read A systematic review investigating the safety and efficacy of intravenous iron in people with ND-CKD who are iron deficient but not anaemic by Sebastian Spencer, Megan Skidmore, Rosa Maeve McGing, Sunil Bhandari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13335104.txt.
Description
Sebastian Spencer and colleagues review 2026 IV iron safety and efficacy in people with kidney disease not yet needing dialysis who are iron deficient but not anaemic. The role of IV iron in this group remains uncertain. Iron deficiency in kidney disease is common and linked to impaired cell energy function, fatigue, thinking decline, and restless legs syndrome, even when haemoglobin levels are normalized.
Databases were searched for random trials and cohort studies involving adults with kidney disease not yet needing dialysis and kidney filter rate below sixty. Patients received IV iron compared with oral iron, placebo, or no treatment. The primary outcome was change in iron levels. Secondary outcomes included heart and vessel events, infections, physical function, symptoms, thinking, and quality of life. Six studies met the inclusion criteria, with pooled trial analyses showing improved iron levels.
Catalog record
| CREATOR | Sebastian Spencer, Megan Skidmore, Rosa Maeve McGing, Sunil Bhandari |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |